Maria V. Yusenko

455 total citations
14 papers, 387 citations indexed

About

Maria V. Yusenko is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Maria V. Yusenko has authored 14 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 2 papers in Organic Chemistry. Recurrent topics in Maria V. Yusenko's work include Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (5 papers). Maria V. Yusenko is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Protein Degradation and Inhibitors (5 papers). Maria V. Yusenko collaborates with scholars based in Germany, Russia and Sweden. Maria V. Yusenko's co-authors include Kirill V. Yusenko, Sephira Riva, Serena Arnaboldi, S. А. Gromilov, Michael Hanfland, A. S. Sukhikh, P.A. Carvalho, Karl‐Heinz Klempnauer, Göran Stenman and Mattias K. Andersson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Acta Materialia.

In The Last Decade

Maria V. Yusenko

14 papers receiving 382 citations

Peers

Countries citing papers authored by Maria V. Yusenko

Since Specialization

Citations

This map shows the geographic impact of Maria V. Yusenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria V. Yusenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria V. Yusenko more than expected).

Fields of papers citing papers by Maria V. Yusenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria V. Yusenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria V. Yusenko. The network helps show where Maria V. Yusenko may publish in the future.

Co-authorship network of co-authors of Maria V. Yusenko

This figure shows the co-authorship network connecting the top 25 collaborators of Maria V. Yusenko. A scholar is included among the top collaborators of Maria V. Yusenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria V. Yusenko. Maria V. Yusenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities 2023 ·Cancer Drug Resistance ·(unknown), Stephanie Reich, Maria V. Yusenko, Karl‐Heinz Klempnauer, Gerrit Begemann, Rainer Schobert, Bernhard Biersack	3
2	A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties 2022 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Maria V. Yusenko, Karl‐Heinz Klempnauer, (unknown), Khursheed Ahmed, Gerrit Begemann, Rainer Schobert, Bernhard Biersack	4
3	A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells 2022 ·Cancer Letters ·(unknown), Maria V. Yusenko, (unknown), Ramkumar Moorthy, John C. Widen, Wolfgang Dörner, Cyrus Khandanpour, Daniel A. Harki, Karl‐Heinz Klempnauer	10
4	Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner 2022 ·Cells ·(unknown), Maria V. Yusenko, Karl‐Heinz Klempnauer	5
5	C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia 2021 ·Oncogene ·Maria V. Yusenko, (unknown), Débora A. Casolari, (unknown), (unknown), (unknown), Wolfgang Dörner, (unknown), Henning D. Mootz, Marı́a Francisca Arteaga, Jan‐Henrik Mikesch, Richard J. D’Andrea, Thomas J. Gonda, Carsten Müller‐Tidow, Thomas J. Schmidt, Karl‐Heinz Klempnauer	16
6	Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity 2021 ·Cancers ·Maria V. Yusenko, (unknown), (unknown), (unknown), Mattias K. Andersson, Cyrus Khandanpour, Rainer Schobert, Göran Stenman, Bernhard Biersack, Karl‐Heinz Klempnauer	13
7	Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner 2021 ·Cancer Letters ·Maria V. Yusenko, (unknown), Mattias K. Andersson, Silke Radetzki, Jens Peter von Kries, Göran Stenman, Karl‐Heinz Klempnauer	18
8	Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824 2021 ·SHILAP Revista de lepidopterología ·Maria V. Yusenko, Karl‐Heinz Klempnauer	4
9	Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells 2020 ·Cancer Letters ·Maria V. Yusenko, (unknown), Mattias K. Andersson, (unknown), (unknown), Marı́a Francisca Arteaga, Jan‐Henrik Mikesch, Jens Peter von Kries, Göran Stenman, Karl‐Heinz Klempnauer	50
10	IL6 Shapes an Inflammatory Microenvironment and Triggers the Development of Unique Types of Cancer in End-stage Kidney 2019 ·Anticancer Research ·(unknown), Maria V. Yusenko, Gyula Kovács	7
11	A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity 2018 ·Scientific Reports ·Maria V. Yusenko, (unknown), Karl‐Heinz Klempnauer	24
12	Ir–Re binary alloys under extreme conditions and their electrocatalytic activity in methanol oxidation 2017 ·Acta Materialia ·Kirill V. Yusenko, Elena Bykova, Maxim Bykov, Sephira Riva, Wilson A. Crichton, Maria V. Yusenko, A. S. Sukhikh, Serena Arnaboldi, Michael Hanfland, Leonid Dubrovinsky, S. А. Gromilov	15
13	First hexagonal close packed high-entropy alloy with outstanding stability under extreme conditions and electrocatalytic activity for methanol oxidation 2017 ·Scripta Materialia ·Kirill V. Yusenko, Sephira Riva, P.A. Carvalho, Maria V. Yusenko, Serena Arnaboldi, A. S. Sukhikh, Michael Hanfland, S. А. Gromilov	210
14	High-throughput powder X-ray diffraction, IR-spectroscopy and ion chromatography analysis of urinary stones: A comparative study 2013 ·SHILAP Revista de lepidopterología ·(unknown), Kirill V. Yusenko, Ilya V. Korolkov, (unknown), (unknown), (unknown), Maria V. Yusenko	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact